EXELON CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that EXELON CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $24.26B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $23.03B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $21.73B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $19.08B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $17.94B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $16.66B | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | $8.34B | Feb 11, 2020 |
| FY2019 | Sep 30, 2019 | $8.93B | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | $7.69B | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | $9.48B | Feb 11, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $378.00M | Feb 22, 2013 |
| FY2012 | Sep 30, 2012 | $296.00M | Feb 22, 2013 |
| FY2012 | Jun 30, 2012 | $286.00M | Feb 22, 2013 |
| FY2012 | Mar 31, 2012 | $200.00M | Feb 22, 2013 |
| FY2011 | Dec 31, 2011 | $606.00M | Feb 9, 2012 |
| FY2011 | Sep 30, 2011 | $601.00M | Feb 9, 2012 |
| FY2011 | Jun 30, 2011 | $620.00M | Feb 9, 2012 |
| FY2011 | Mar 31, 2011 | $668.00M | Feb 9, 2012 |
| FY2010 | Dec 31, 2010 | $524.00M | Feb 10, 2011 |
| FY2010 | Sep 30, 2010 | $845.00M | Feb 10, 2011 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.15B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $4.32B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $4.02B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $3.32B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $2.68B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $2.19B | Feb 14, 2023 |
| FY2019 | Dec 31, 2019 | $962.00M | Feb 11, 2020 |
| FY2019 | Sep 30, 2019 | $1.35B | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | $841.00M | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | $1.22B | Feb 11, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.25B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $5.57B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $4.70B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $4.87B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $3.01B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $4.24B | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $6.66B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $8.64B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $7.48B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $8.46B | Feb 8, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.53B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $7.10B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $7.41B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $7.15B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $7.98B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $8.05B | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $7.25B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $7.59B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $7.58B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $8.55B | Feb 8, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $116.57B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $107.78B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $101.86B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $95.35B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $133.01B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $129.32B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $124.98B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $119.63B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $116.77B | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | $114.90B | Feb 9, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $87.77B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $80.86B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $76.10B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $70.61B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $98.22B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $94.45B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $90.40B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $86.59B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $84.58B | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | $87.29B | Feb 9, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.80B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $26.92B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $25.76B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $24.74B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $34.39B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $32.59B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $32.22B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $30.74B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $29.90B | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | $25.84B | Feb 9, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.63B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $6.63B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $6.63B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $6.63B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $6.63B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $6.68B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $6.68B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $6.68B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $6.68B | Feb 8, 2019 |
| FY2018 | Dec 31, 2016 | $6.68B | Feb 8, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $7.58B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $6.43B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | $5.49B | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | $4.60B | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | $16.94B | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | $16.74B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $16.27B | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | $14.74B | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | $14.08B | Feb 8, 2019 |
| FY2017 | Dec 31, 2016 | $12.03B | Feb 9, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $626.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $357.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $445.00M | Feb 12, 2026 |
| FY2025 | Dec 31, 2022 | $407.00M | Feb 12, 2026 |
| FY2024 | Dec 31, 2021 | $672.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2020 | $432.00M | Feb 21, 2024 |
| FY2022 | Dec 31, 2019 | $587.00M | Feb 14, 2023 |
| FY2021 | Dec 31, 2018 | $1.35B | Feb 25, 2022 |
| FY2020 | Dec 31, 2017 | $898.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2016 | $635.00M | Feb 11, 2020 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $49.43B | Feb 12, 2026 |
| FY2024 | Dec 31, 2024 | $44.67B | Feb 12, 2025 |
| FY2023 | Dec 31, 2023 | $41.28B | Feb 21, 2024 |
| FY2022 | Dec 31, 2022 | $37.17B | Feb 14, 2023 |
| FY2021 | Dec 31, 2021 | $38.76B | Feb 25, 2022 |
| FY2020 | Dec 31, 2020 | $36.91B | Feb 24, 2021 |
| FY2019 | Dec 31, 2019 | $35.95B | Feb 11, 2020 |
| FY2018 | Dec 31, 2018 | $35.30B | Feb 8, 2019 |
| FY2017 | Dec 31, 2017 | $34.05B | Feb 9, 2018 |
| FY2016 | Dec 31, 2016 | $33.96B | Feb 13, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 1 | Feb 25, 2022 |
| FY2021 | Dec 31, 2020 | 2 | Feb 25, 2022 |
| FY2019 | Dec 31, 2019 | 0 | Feb 11, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 11, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Feb 11, 2020 |
| FY2019 | Sep 30, 2018 | 0 | Feb 11, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Feb 11, 2020 |
| FY2019 | Mar 31, 2018 | 0 | Feb 11, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | 1 | Feb 25, 2022 |
| FY2021 | Dec 31, 2020 | 2 | Feb 25, 2022 |
| FY2019 | Dec 31, 2019 | 0 | Feb 11, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Feb 11, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Feb 11, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Feb 11, 2020 |
| FY2019 | Dec 31, 2018 | 0 | Feb 11, 2020 |
| FY2019 | Sep 30, 2018 | 0 | Feb 11, 2020 |
| FY2019 | Jun 30, 2018 | 0 | Feb 11, 2020 |
| FY2019 | Mar 31, 2018 | 0 | Feb 11, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.02B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | 1.01B | Feb 12, 2026 |
| FY2024 | Dec 31, 2023 | 999.00M | Feb 12, 2025 |
| FY2023 | Dec 31, 2022 | 994.00M | Feb 21, 2024 |
| FY2022 | Dec 31, 2021 | 979.00M | Feb 14, 2023 |
| FY2021 | Dec 31, 2020 | 976.00M | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | 973.00M | Feb 24, 2021 |
| FY2019 | Dec 31, 2018 | 968.00M | Feb 11, 2020 |
| FY2018 | Dec 31, 2017 | 963.34M | Feb 8, 2019 |
| FY2016 | Dec 31, 2016 | 924.04M | Feb 13, 2017 |
Dividends Paid
Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.62B | Feb 12, 2026 |
| FY2025 | Dec 31, 2024 | $1.52B | Feb 12, 2026 |
| FY2025 | Dec 31, 2023 | $1.43B | Feb 12, 2026 |
| FY2024 | Dec 31, 2022 | $1.33B | Feb 12, 2025 |
| FY2023 | Dec 31, 2021 | $1.50B | Feb 21, 2024 |
| FY2022 | Dec 31, 2020 | $1.49B | Feb 14, 2023 |
| FY2021 | Dec 31, 2019 | $1.41B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.33B | Feb 24, 2021 |
| FY2019 | Dec 31, 2017 | $1.24B | Feb 11, 2020 |
| FY2018 | Dec 31, 2016 | $1.17B | Feb 8, 2019 |